/ELV
ELV Stock - Elevance Health Inc.
Healthcare|Medical - Healthcare PlansNYSE
$370.68-1.14%
$4.29 (-1.14%) • Jan 13
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.73
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).61
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.99
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+5.3%upside
Target: $390.33
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ELV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$366.97 – $374.39
TARGET (TP)$390.46
STOP LOSS$341.03
RISK/REWARD1:0.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.52
52W High$458.75
52W Low$273.71
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $176.81B | $171.34B | $156.59B | $138.64B | $121.87B |
| Gross Profit | $176.81B | $171.34B | $156.59B | $138.64B | $121.87B |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $7.90B | $7.71B | $7.60B | $8.00B | $6.24B |
| Net Income | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B |
| Net Margin | 3.4% | 3.5% | 3.8% | 4.4% | 3.8% |
| EPS | $25.81 | $25.38 | $24.56 | $25.25 | $18.23 |
Company Overview
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ELVBeat Rate
89%
Last 18 quarters
Avg Surprise
+3.5%
EPS vs Estimate
Beats / Misses
16/2
Last 12 quarters
Latest EPS
$6.03
Q4 2025
EPS Surprise History
Q1 24
+1.3%
$5.62vs$5.55
Q2 24
+1.0%
$10.64vs$10.53
Q3 24
+1.1%
$10.12vs$10.01
Q4 24
-13.4%
$8.37vs$9.66
Q1 25
+1.1%
$3.84vs$3.80
Q2 25
+4.9%
$11.97vs$11.41
Q3 25
-0.8%
$8.84vs$8.91
Q4 25
+22.3%
$6.03vs$4.93
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 20, 2026 | — | — | — | — |
Q1 2026 | Jan 28, 2026 | $3.10 | — | — | — |
Q4 2025 | Oct 21, 2025 | $4.93 | $6.03 | +22.3% | ✓ BEAT |
Q3 2025 | Jul 17, 2025 | $8.91 | $8.84 | -0.8% | ✗ MISS |
Q2 2025 | Apr 22, 2025 | $11.41 | $11.97 | +4.9% | ✓ BEAT |
Q1 2025 | Jan 23, 2025 | $3.80 | $3.84 | +1.1% | ✓ BEAT |
Q4 2024 | Oct 17, 2024 | $9.66 | $8.37 | -13.4% | ✗ MISS |
Q3 2024 | Jul 17, 2024 | $10.01 | $10.12 | +1.1% | ✓ BEAT |
Q2 2024 | Apr 18, 2024 | $10.53 | $10.64 | +1.0% | ✓ BEAT |
Q1 2024 | Jan 24, 2024 | $5.55 | $5.62 | +1.3% | ✓ BEAT |
Q4 2023 | Oct 18, 2023 | $8.45 | $8.99 | +6.4% | ✓ BEAT |
Q3 2023 | Jul 19, 2023 | $8.80 | $9.04 | +2.7% | ✓ BEAT |
Q2 2023 | Apr 19, 2023 | $9.26 | $9.46 | +2.2% | ✓ BEAT |
Q1 2023 | Jan 25, 2023 | $5.20 | $5.23 | +0.6% | ✓ BEAT |
Q4 2022 | Oct 19, 2022 | $7.15 | $7.53 | +5.3% | ✓ BEAT |
Q3 2022 | Jul 20, 2022 | $7.74 | $8.04 | +3.9% | ✓ BEAT |
Q2 2022 | Apr 20, 2022 | $7.81 | $8.25 | +5.6% | ✓ BEAT |
Q1 2022 | Jan 26, 2022 | $5.11 | $5.14 | +0.6% | ✓ BEAT |
Q4 2021 | Oct 20, 2021 | $6.37 | $6.79 | +6.6% | ✓ BEAT |
Q3 2021 | Jul 21, 2021 | $6.33 | $7.03 | +11.1% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about ELV
What is ELV's current stock price?
Elevance Health Inc. (ELV) is currently trading at $370.68 per share. The stock has moved -1.14% today.
What is the analyst price target for ELV?
The average analyst price target for ELV is $390.46, based on 1 analyst.
What sector is Elevance Health Inc. in?
Elevance Health Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry. The company is traded on the NYSE exchange.
What is ELV's market cap?
Elevance Health Inc. has a market capitalization of $82.38 billion, making it a large-cap company.
Does ELV pay dividends?
No, Elevance Health Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBDX
Becton, Dickinson and Company
$201.52
Mkt Cap: $58.0B
CI
Cigna Corporation
$271.81
Mkt Cap: $72.6B
COR
Cencora, Inc.
$345.88
Mkt Cap: $67.0B
CVS
CVS Health Corporation
$80.68
Mkt Cap: $102.4B
GEHC
GE HealthCare Technologies Inc.
$84.77
Mkt Cap: $38.7B
GSK
GSK plc
$49.90
Mkt Cap: $101.5B
HUM
Humana Inc.
$273.96
Mkt Cap: $33.0B
IDXX
IDEXX Laboratories, Inc.
$714.04
Mkt Cap: $57.0B
REGN
Regeneron Pharmaceuticals, Inc.
$758.91
Mkt Cap: $78.4B
ZTS
Zoetis Inc.
$124.62
Mkt Cap: $54.9B
Explore stocks similar to ELV for comparison